HSDT
Helius Medical Technologies Inc Class ANASDAQFINANCIAL SERVICESASSET MANAGEMENT
Key Statistics
Market Cap
$133.71M
P/E Ratio
0.01
EPS
$379.14
Beta
1.07
52W High
$205.00
52W Low
$1.59
50-Day MA
$2.08
200-Day MA
$5.12
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
0.00
About Helius Medical Technologies Inc Class A
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Fundamentals
| Revenue (TTM) | $9.59M |
| Gross Profit (TTM) | $9.03M |
| EBITDA | $-338.60M |
| Operating Margin | -2751.00% |
| Return on Equity | -137.40% |
| Return on Assets | -207.80% |
| Revenue/Share (TTM) | $0.23 |
| Book Value | $6.88 |
| Price-to-Book | 0.68 |
| Price-to-Sales (TTM) | 13.94 |
| EV/Revenue | 13.83 |
| EV/EBITDA | -0.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 7290.00% |
| Shares Outstanding | $58.39M |
| Float | $39.93M |
| % Insiders | 20.52% |
| % Institutions | 26.24% |
Historical Volatility
HV 10-Day
79.50%
HV 20-Day
64.29%
HV 30-Day
64.89%
HV 60-Day
82.71%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($3.50 target)
1
Strong Buy1
BuyMore FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026